English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
European Medicines Agency
Erianne Leatherman
| Jun 6, 2017
Zykadia under consideration in Europe for expanded use to treat non-small cell lung cancer
Robert Hadley
| Apr 16, 2017
XGEVA pending approval for myeloma patients
Ruth de Jauregui
| Apr 9, 2017
Bruno Farmaceutici, Orexigen Therapeutics Ireland to distribute Mysimba in Italy
Ruth de Jauregui
| Apr 3, 2017
European Medicines Agency recommends Keytruda for approval
Ruth de Jauregui
| Apr 3, 2017
Inebilizumab receives orphan status from EMA for optic nerve disorder treatment
Robert Hadley
| Mar 30, 2017
Europe to evaluate antipsychotic drug for approval
Trending
+
Marketing
Patient Daily
| Sep 17, 2025
Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'
+
Pharmaceuticals
Patient Daily
| Sep 23, 2025
Wall Street Journal editorial board alleges hospitals misuse 340B program
+
Regulatory
Patient Daily
| Sep 17, 2025
PhRMA’s Senior Director on 340B: 'State and federal investigations have shown 340B is often exploited for profit'
+
Pharmaceuticals
Patient Daily
| Sep 22, 2025
Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
